Atlas Trials

Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects

Clinical trial NCT02621489 · COMPLETED

Trial details

NCT number
NCT02621489
Sponsor
Karolinska Institutet
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
AtherosclerosisDiabetesRestenosis
Start date
2015-12-01
Primary completion
2022-08-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.